Arnatar Therapeutics

Series-A
arnatar.com Biotech & Healthcare San Diego, United States 11-50
Total Funding $52M
Latest Round Undisclosed Series-A
Last Announced Mar 14, 2026
Investors 10 Backers
Decision Makers 4 Verified

About Arnatar Therapeutics

We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, liver, and kidney diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Diego, United States
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website arnatar.com
Domain Registered Date Dec 11, 2021

Social & Network Presence

X / Twitter Profile @ArnatarThera (8 followers) Created on Jun 2025
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-A announced

    startupintros.com

  2. Capital Raise

    Raised $52,000,000 · Series-A

    startupintros.com

  3. Milestone

    X account created (@ArnatarThera)

    8 followers

  4. Milestone

    Website domain registered

    arnatar.com

Investors & Backers

10
3E Bioventures
Eight Roads Ventures
F-Prime Capital
Gaorong Capital
Hongsheng Capital
Huajin Capital
jifeng ventures
New Alliance Capital
Transfar Capital
Yijing Capital

Funding History

2 Rounds
Series-A · Mar 14, 2026
Series-A · Aug 25, 2025

Founders & Leadership

2

Xuehai Liang

Co-founder & Chief Executive Officer

Work email & phone locked Unlock →

Yanfeng Wang

Co-founder & Chief Operating Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts